1. Home
  2. MVIS vs CRBU Comparison

MVIS vs CRBU Comparison

Compare MVIS & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroVision Inc.

MVIS

MicroVision Inc.

HOLD

Current Price

$0.65

Market Cap

186.2M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.14

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVIS
CRBU
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.2M
179.7M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MVIS
CRBU
Price
$0.65
$2.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$2.25
$10.75
AVG Volume (30 Days)
3.4M
1.3M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
23.91
3.64
EPS
N/A
N/A
Revenue
$664,000.00
N/A
Revenue This Year
$529.06
$1.63
Revenue Next Year
$168.46
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.73
52 Week High
$1.73
$3.53

Technical Indicators

Market Signals
Indicator
MVIS
CRBU
Relative Strength Index (RSI) 49.45 53.56
Support Level $0.51 $1.70
Resistance Level $0.73 $2.26
Average True Range (ATR) 0.04 0.12
MACD 0.00 0.01
Stochastic Oscillator 51.89 50.91

Price Performance

Historical Comparison
MVIS
CRBU

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: